MedTrace Logo

Seroepidemiological Study of Pertussis and Other Infectious Diseases

NCT01929473 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3830

Last updated 2016-07-12

Study results available
· View outcomes & findings →

Summary

Serum samples will be corrected twice from the same youth subjects with one year interval.

Seroincidence of pertussis will be estimated by the elevation of Ig-G-PT in paired sera from an identical individual.

The relationship between the incidence and the demographic data or medical history of the subjects will be discussed.

Conditions

  • Pertussis Infection

Sponsors & Collaborators

  • Sanofi Pasteur S.A.

    collaborator UNKNOWN

  • Gifu Prefecture Medical Association

    lead OTHER

Principal Investigators

  • Naoki Kawai · Gifu Prefecture Medial Association

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01929473 on ClinicalTrials.gov